A detailed history of Schwerin Boyle Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Schwerin Boyle Capital Management Inc holds 4,511 shares of BMY stock, worth $260,555. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,511
Previous 5,461 17.4%
Holding current value
$260,555
Previous $226,000 3.1%
% of portfolio
0.02%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $37,677 - $49,162
-950 Reduced 17.4%
4,511 $233,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $15,514 - $17,347
-268 Reduced 4.68%
5,461 $316,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $226,170 - $251,126
-3,550 Reduced 38.26%
5,729 $366,000
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $52,830 - $59,922
804 Added 9.49%
9,279 $643,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $10,726 - $12,504
-200 Reduced 2.31%
8,475 $528,000
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $233,710 - $254,510
3,775 Added 77.04%
8,675 $580,000
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $282,926 - $320,607
4,900 New
4,900 $304,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Schwerin Boyle Capital Management Inc Portfolio

Follow Schwerin Boyle Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwerin Boyle Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwerin Boyle Capital Management Inc with notifications on news.